PMID- 26109305 OWN - NLM STAT- MEDLINE DCOM- 20150910 LR - 20190318 IS - 0371-0874 (Print) IS - 0371-0874 (Linking) VI - 67 IP - 3 DP - 2015 Jun 25 TI - The role of the TLR4/NF-kappaB signaling pathway in Abeta accumulation in primary hippocampal neurons. PG - 319-28 AB - The present study aimed to investigate the role of the Toll-like receptor 4 (TLR4)/nuclear factor kappaB (NF-kappaB) signaling pathway in the accumulation of amyloid beta protein (Abeta) in primary hippocampal neurons of rats. The purity of these cultured neurons was determined by using immunofluorescence techniques. Lipopolysaccharide (LPS, a TLR4 ligand) or CLI-095 (a TLR4 inhibitor) was used to activate or inhibit TLR4 signaling, respectively. Pyrrolidine dithiocarbamate (PDTC), on the other hand, was used to inhibit NF-kappaB, a downstream effector of the TLR4 signaling pathway. The contents of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta) and Abeta1-42 in the supernatant were assessed by enzyme-linked immunosorbent assay (ELISA). The mRNA levels of TNF-alpha, IL-1beta, a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10), beta-site APP cleaving enzyme 1 (BACE-1), Presenilin-1 (PS-1), and beta-amyloid precursor protein (beta-APP) were examined by real-time quantitative PCR (RT-qPCR). The protein levels of ADAM10, BACE-1, PS-1 and beta-APP were examined by Western blotting. Meanwhile, the levels of TLR4 mRNA and protein in hippocampal neurons were tested by RT-qPCR and Western blotting, respectively, after stimulation with Abeta1-42 at different concentrations. We observed that the purity of cultured hippocampal neurons after being cultured for 7 days was above 95%. Compared with untreated neurons, LPS-treated neurons showed higher expression levels of TNF-alpha, IL-1beta, BACE-1, PS-1, beta-APP, and Abeta1-42, but a lower expression level of ADAM10. These effects were reversed upon pre-treatment with CLI-095 or PDTC. Furthermore, TLR4 expression was upregulated in the presence of Abeta1-42. Taken together, these results provide evidence that elevation in the level of inflammatory cytokines accompanies the activation of TLR4 signaling, and that the consequent downregulation of ADAM10 and upregulation of BACE-1/PS-1 are likely responsible for the accumulation of beta-APP and Abeta, which in turn increases TLR4 level to create a positive feedback loop that may constitute the basis for the progression of Alzheimer's disease. FAU - Wu, Dan AU - Wu D AD - Department of Pathophysiology, Medical School of Nantong University, Nantong 226001, China. AD - Department of Neurology, Affiliated Hospital of Nantong University, Nantong 226001, China. FAU - Zhang, Xian AU - Zhang X AD - Department of Infectious Disease, Affiliated Hospital of Nantong University, Nantong 226001, China. FAU - Zhao, Min AU - Zhao M AD - Department of Pathology, Nantong Tumour Hospital, Nantong 226001, China. FAU - Zhou, Ai-Ling AU - Zhou AL AD - Department of Pathophysiology, Medical School of Nantong University, Nantong 226001, China. ALZ@ntu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Sheng Li Xue Bao JT - Sheng li xue bao : [Acta physiologica Sinica] JID - 20730130R RN - 0 (Amyloid beta-Peptides) RN - 0 (Interleukin-1beta) RN - 0 (Lipopolysaccharides) RN - 0 (NF-kappa B) RN - 0 (Peptide Fragments) RN - 0 (RNA, Messenger) RN - 0 (Sulfonamides) RN - 0 (Tlr4 protein, rat) RN - 0 (Toll-Like Receptor 4) RN - 0 (Tumor Necrosis Factor-alpha) RN - 0 (amyloid beta-protein (1-42)) RN - 0 (ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate) SB - IM MH - Alzheimer Disease MH - Amyloid beta-Peptides/*metabolism MH - Animals MH - Cells, Cultured MH - Hippocampus/cytology MH - Interleukin-1beta/metabolism MH - Lipopolysaccharides MH - NF-kappa B/*metabolism MH - Neurons/*metabolism MH - Peptide Fragments/metabolism MH - RNA, Messenger MH - Rats MH - *Signal Transduction MH - Sulfonamides MH - Toll-Like Receptor 4/*metabolism MH - Tumor Necrosis Factor-alpha/metabolism EDAT- 2015/06/26 06:00 MHDA- 2015/09/12 06:00 CRDT- 2015/06/26 06:00 PHST- 2015/06/26 06:00 [entrez] PHST- 2015/06/26 06:00 [pubmed] PHST- 2015/09/12 06:00 [medline] PST - ppublish SO - Sheng Li Xue Bao. 2015 Jun 25;67(3):319-28.